Aktiesnakken — Oktober 2009
-
strengt... i er foran mig.
-
newer say newer, but no plans about
-
no imidiate plan about raising money
-
kan ikke kommentere på det . Men vil ikke udelukke det
-
men en biotech executive vil du aldrig få til at sige never raise more money.
-
Vidste det!!!!
-
we have the earnings we need
-
Ok så er den nok død nu
-
hvor betydningsfuldt er det af egfr først kommer q12010? - hvor meget er der i det?
-
muligvis class effekt med cd20 vs PML
-
Det kommer. Ellers kan jeg hverken det ene eller det andet
-
men pt kun én patient med arzerra der har fået pml
-
om milestone er mindre end de havde regnet med, pga. kun en godkendelse
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind